FDA Inspection
Piedmont LLCPiedmont LLC – FDA Inspection, Oct 4, 2017
Record Details
This FDA Inspection record concerns Piedmont LLC, with an inspection on October 4, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e23bdd9c-62f7-4eb6-9616-69c24c322f52
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1027754
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.198(b)(3)Reason for Not Conducting Complaint Investigation
- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.68(a)Written calibration / inspection records not kept
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Piedmont LLC
11| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | VAI | Atlanta District Office | Drug Quality Assurance |
| March 30, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 12, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Piedmont LLC
- FDA Inspection 1269868 - 2025-05-09
- FDA Inspection 924354 - 2015-03-30
- FDA Inspection 924637 - 2015-03-27
- FDA Inspection 924370 - 2015-03-27
- FDA Inspection 804096 - 2012-10-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.